Activated Protein C and Acute Kidney Injury: Selective Targeting of PAR-1
Journal:
Current Drug Targets
Volume:
10
Page:
1212-1226
Author(s):
Akanksha Gupta, Mark D. Williams, William L. Macias, Bruce A. Molitoris and Brian W. Grinnell
Targeting Matrix Metalloproteinases in Inflammatory Conditions
Journal:
Current Drug Targets
Volume:
10
Page:
1245-1254
Author(s):
A. L. Clutterbuck, K. E. Asplin, P. Harris, D. Allaway and A. Mobasheri
The Protein Therapy of Kallikrein in Cerebral Ischemic Reperfusion Injury
Journal:
Current Medicinal Chemistry
Volume:
16
Page:
4502-4510
Author(s):
Y. Tang, Y. Shao, J. Su, H. Zhou, L. Liu, H. Ren and Q. Dong
Hypoxia Inducible Factor 1 as a Therapeutic Target in Ischemic Stroke
Journal:
Current Medicinal Chemistry
Volume:
16
Page:
4593-4600
Author(s):
Honglian Shi
Sexual Dimorphism in Autoimmune Disease
Journal:
Current Molecular Medicine
Volume:
9
Page:
1058-1079
Author(s):
P. A. McCombe, J. M. Greer and I. R. Mackay
Ribosome Inactivating Proteins (RIPs) from Momordica charantia for Anti Viral Therapy
Journal:
Current Molecular Medicine
Volume:
9
Page:
1080-1094
Author(s):
M. Puri, I. Kaur, R. K. Kanwar, R. C. Gupta, A. Chauhan and J. R. Kanwar
Syntheses, Transformations and Pharmaceutical Applications of Kynurenic Acid Derivatives
Journal:
Current Medicinal Chemistry
Volume:
16
Page:
4828-4842
Author(s):
F. Fulop, I. Szatmari, E. Vamos, D. Zadori, J. Toldi and L. Vecsei
Omega-3 Polyunsaturated Fatty Acids and Depression: A Review of the Evidence
Journal:
Current Pharmaceutical Design
Volume:
15
Page:
4165-4172
Author(s):
R. Liperoti, F. Landi, O. Fusco, R. Bernabei and G. Onder
PUFA for Prevention and Treatment of Dementia?
Journal:
Current Pharmaceutical Design
Volume:
15
Page:
4173-4185
Author(s):
Carrie I., Abellan Van Kan G., Rolland Y., Gillette-Guyonnet S. and Vellas B.
MMP-9, a Potential Target for Cerebral Ischemic Treatment
Journal:
Current Neuropharmacology
Volume:
7
Page:
269-275
Author(s):
Xue Dong, Yu-Ning Song, Wei-Guo Liu and Xiu-Li Guo